Wet Macular Degeneration Clinical Trials 2022

Browse 20 Wet Macular Degeneration Medical Studies Across 183 Cities

8 Phase 3 Trial · 382 Wet Macular Degeneration Clinics

Reviewed by Michael Gill, B. Sc.
20 Wet Macular Degeneration Clinical Trials Near Me
Jacksonville, FL
Phoenix, AZ
Fullerton, CA
'Aiea, HI
More Trial Locations
An interactive map to display trial locations for Adverum Clinical Site, Retina Consultants San Diego, Florida Eye Associates, Colorado Retina, and 166 more locations.
Most Popular References for Wet Macular Degeneration Clinical Trials
Frequency
Citation
Top Hospitals for Wet Macular Degeneration Clinical Trials
Location
Active Wet Macular Degeneration Clinical Trials
All Time Trials for Wet Macular Degeneration
First Recorded Wet Macular Degeneration Trial
Trials
Retina Consultants of Texas, The Woodlands, Texas
2
2
2020
Top Treatments for Wet Macular Degeneration Clinical Trials
Treatment Name
Active Wet Macular Degeneration Clinical Trials
All Time Trials for Wet Macular Degeneration
First Recorded Wet Macular Degeneration Trial
Trials
Top Cities for Wet Macular Degeneration Clinical Trials
How many wet macular degeneration clinical trials are open to youth and / or seniors?
Most Recent Wet Macular Degeneration Clinical Trials
Phase 3 Wet Macular Degeneration Clinical Trials
Senior Friendly Wet Macular Degeneration Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Wet Macular Degeneration
Treatment
Year
Mechanism of Action
Sponsor
Active Wet Macular Degeneration Clinical Trials
GEM103
2020
Gemini Therapeutics, Inc.
0
UBX1325
2020
Unity Biotechnology, Inc.
0
SB15 (Proposed aflibercept biosimilar)
2020
Aflibercept
Samsung Bioepis Co., Ltd.
5
AR-13503 63.6 Dose
2019
Aerie Pharmaceuticals
0
Faricimab
2019
Faricimab
Hoffmann-La Roche
1
Faricimab
2019
Faricimab
Hoffmann-La Roche
1

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 14th, 2021

Last Reviewed: August 23rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.